Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CB1 receptor antagonists: new discoveries leading to new perspectives
Eszter Kirilly, Xénia Gonda, György Bagdy
Acta Physiologica (2011) Vol. 205, Iss. 1, pp. 41-60
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam, L Hanŭs, Roger G. Pertwee, et al.
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 757-764
Closed Access | Times Cited: 345
Plasticity of Inhibition
Dimitri M. Kullmann, Alexandre Moreau, Yamina Bakiri, et al.
Neuron (2012) Vol. 75, Iss. 6, pp. 951-962
Open Access | Times Cited: 225
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202
Metabolic effects of smoking cessation
Kindred K. Harris, Mohan Zopey, Theodore C. Friedman
Nature Reviews Endocrinology (2016) Vol. 12, Iss. 5, pp. 299-308
Open Access | Times Cited: 165
Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition
Daisuke Ogasawara, Hui Deng, Andreu Viader, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 113, Iss. 1, pp. 26-33
Open Access | Times Cited: 141
The Endocannabinoid Signaling System in the CNS
Cecilia J. Hillard
International review of neurobiology (2015), pp. 1-47
Open Access | Times Cited: 111
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma
Judit Lazáry, Nóra Eszlári, Gabriella Juhász, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 6, pp. 1020-1028
Open Access | Times Cited: 75
Prospective therapeutic agents for obesity: Molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists
Mayank Sharma, Prashant R. Murumkar, Ashish M. Kanhed, et al.
European Journal of Medicinal Chemistry (2014) Vol. 79, pp. 298-339
Closed Access | Times Cited: 64
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats
Jing Li, Yanyan Qiu, Yanan Zhang, et al.
Drug and Alcohol Dependence (2014) Vol. 143, pp. 251-256
Open Access | Times Cited: 61
Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes
Viola Tamási, Péter Petschner, Csaba Ádori, et al.
PLoS ONE (2014) Vol. 9, Iss. 11, pp. e113662-e113662
Open Access | Times Cited: 57
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence
Vishakh Iyer, Richard A. Slivicki, Ana C. Thomaz, et al.
European Journal of Pharmacology (2020) Vol. 886, pp. 173544-173544
Open Access | Times Cited: 42
Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Mental Health and Stress Response
Musab Işık, Fadime Köse, Cansu Özbayer, et al.
Probiotics and Antimicrobial Proteins (2025)
Open Access
The pentafluorosulfanyl group in cannabinoid receptor ligands: synthesis and comparison with trifluoromethyl and tert-butyl analogues
Stefano Altomonte, Gemma L. Baillie, Ruth A. Ross, et al.
RSC Advances (2014) Vol. 4, Iss. 39, pp. 20164-20176
Closed Access | Times Cited: 48
Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
Corbin Bachmeier, David Beaulieu‐Abdelahad, Michael Mullan, et al.
Molecular and Cellular Neuroscience (2013) Vol. 56, pp. 255-262
Closed Access | Times Cited: 46
Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling
Andrea Balla, Bin Dong, B. M. Shilpa, et al.
Neuropharmacology (2017) Vol. 131, pp. 200-208
Open Access | Times Cited: 41
Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
Pedro Melgar‐Lesmes, Meritxell Perramón, Wladimiro Jiménez
Cells (2019) Vol. 8, Iss. 11, pp. 1311-1311
Open Access | Times Cited: 35
Cannabinoid Discrimination and Antagonism by CB1Neutral and Inverse Agonist Antagonists
Brian D. Kangas, Marcus S. Delatte, Kiran Vemuri, et al.
Journal of Pharmacology and Experimental Therapeutics (2013) Vol. 344, Iss. 3, pp. 561-567
Open Access | Times Cited: 43
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats
Yuanyuan Ding, Yanyan Qiu, Jing Li, et al.
Pharmacology Research & Perspectives (2014) Vol. 2, Iss. 6
Open Access | Times Cited: 39
Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9‐tetrahydrocannabinol‐induced central nervous system and heart rate effects in humans
Linda E. Klumpers, Christine Le Roy, Géraldine M. Ferron, et al.
British Journal of Clinical Pharmacology (2012) Vol. 76, Iss. 1, pp. 65-77
Open Access | Times Cited: 37
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
Alexander Fuchs, Viktor Rempel, Christa E. Müller
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e77739-e77739
Open Access | Times Cited: 35
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists
Eszter Kirilly, László Hunyady, György Bagdy
Journal of Neural Transmission (2012) Vol. 120, Iss. 1, pp. 177-186
Closed Access | Times Cited: 34
Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors
Gabriella Juhász, Xénia Gonda, Gábor Hullám, et al.
PLoS ONE (2015) Vol. 10, Iss. 3, pp. e0116316-e0116316
Open Access | Times Cited: 33
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
Mateus M. Bergamaschi, Regina Helena Costa Queiróz, Marcos Hortes Nisihara Chagas, et al.
Human Psychopharmacology Clinical and Experimental (2013) Vol. 29, Iss. 1, pp. 94-99
Open Access | Times Cited: 31
NESS06SM reduces body weight with an improved profile relative to SR141716A
Andrea Mastinu, Marilena Pira, Gérard A. Pinna, et al.
Pharmacological Research (2013) Vol. 74, pp. 94-108
Closed Access | Times Cited: 31
Acute and chronic systemic CB1cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats
Christopher L. Schaich, Hossam A. Shaltout, K. Bridget Brosnihan, et al.
Physiological Reports (2014) Vol. 2, Iss. 8, pp. e12108-e12108
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top